We are live on ! Find out more
IRON icon

Disc Medicine

236 hedge funds and large institutions have $2.86B invested in Disc Medicine in 2026 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 94 increasing their positions, 59 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 23

59% more repeat investments, than reductions

Existing positions increased: 94 | Existing positions reduced: 59

23% more capital inflows, than outflows

Capital inflows: $353M | Capital outflows: $287M

11% more call options, than puts

Call options by funds: $83.1M | Put options by funds: $75.2M

8% more funds holding

Funds holding: 218 → 236 (+18)

1.5% more ownership

Funds ownership: 112.08% → 113.58% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

Holders
236
Holders Change
+18
Holders Change %
+8.26%
% of All Funds
2.87%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
44
Increased
94
Reduced
59
Closed
23
Calls
$83.1​M
Puts
$75.2​M
Net Calls
+$7.96​M
Net Calls Change
-⁠$13.9​M

IRON Hedge Fund Activity: Q3 2026 in Review

236 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Disc Medicine (IRON) for Q3 2026, worth a combined $2.86B — down 8.8% from $3.13B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new IRON positions and 23 closed out — a net gain of 21 holders — while 94 added to existing stakes and 59 trimmed.

The largest buyer was Assenagon Asset Management, adding an estimated $55.6M. The largest seller was BVF Inc, cutting an estimated $69.5M.

  • 236 institutional investors held Disc Medicine (IRON) as of Q3 2026, up from 218 in Q2 2026.
  • Funds reported $2.86B of Disc Medicine stock for Q3 2026, down 8.8% quarter-over-quarter.
  • 44 funds opened new Disc Medicine positions in Q3 2026 and 23 closed out, a net change of +21 holders.
  • The largest Disc Medicine buyer in Q3 2026 was Assenagon Asset Management, an estimated $55.6M added.
  • The largest Disc Medicine seller in Q3 2026 was BVF Inc, an estimated $69.5M sold.

Based on aggregated 13F filings for Q3 2026.